Drug
inhaled carbon monoxide
inhaled carbon monoxide is a pharmaceutical drug with 4 clinical trials. Historical success rate of 50.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_2
3
75%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Terminated(2)
Other(1)
Detailed Status
Completed1
Withdrawn1
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 2
Trials by Phase
Phase 23 (75.0%)
N/A1 (25.0%)
Trials by Status
completed125%
withdrawn125%
terminated125%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis
NCT01214187
withdrawnphase_2
Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients
NCT00531856
terminatedphase_2
Study of Inhaling Carbon Monoxide to Treat Patients With Intestinal Paralysis After Colon Surgery.
NCT01050712
unknownnot_applicable
The Safety and Adverse Reaction Study of Neonatal to Inhaled Carbon Monoxide
NCT01818843
Clinical Trials (4)
Showing 4 of 4 trials
NCT01214187Phase 2
Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis
NCT00531856Phase 2
Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients
NCT01050712Phase 2
Study of Inhaling Carbon Monoxide to Treat Patients With Intestinal Paralysis After Colon Surgery.
NCT01818843Not Applicable
The Safety and Adverse Reaction Study of Neonatal to Inhaled Carbon Monoxide
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4